RHB Retail Research

Trading Stocks - Duopharma Biotech

rhboskres
Publish date: Thu, 08 Aug 2019, 05:22 PM
rhboskres
0 9,020
RHB Retail Research

Duopharma Biotech was testing the MYR1.43 level lately. A bullish bias may be present above this point, with a target price of MYR1.50, followed by MYR1.60. The stock may consolidate further if it cannot breach above the MYR1.43 threshold decisively in the near term. Support may be found at MYR1.29, where traders can exit upon a breach to minimise the downside risk.

Source: RHB Securities Research - 8 Aug 2019

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment